FDA OKs First Cell Therapy for Severe Aplastic Anemia – Medscape

1. FDA OKs First Cell Therapy for Severe Aplastic Anemia  Medscape
2. Aplastic Anemia Market Expected to Experience Major Growth by 2034, According to DelveInsight  openPR.com
3. Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia Presented at ASH  Lexington Herald Leader
4. Gamida Cell’s Omisirge becomes first FDA-cleared cell therapy for rare blood disorder  FirstWord Pharma
5. FDA approves omidubicel-onlv as first HSCT therapy to treat severe aplastic anemia  Contemporary Pediatrics

Continue Reading